Transgene SA
EPA:TNG.PA
1.022 (EUR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.184 | 3.126 | 9.993 | 2.981 | 6.652 | 1.335 | 2.099 | 2.346 | 1.465 | 2.49 | 3.849 | 3.928 | 14.446 | 14.112 | 11.765 | 13.949 | 28.019 | 5.546 | 2.514 | 2.501 | 2.206 | 1.26 | 4.724 | 4.325 | 11.667 | 6.711 |
| Cost of Revenue
| 29.588 | 32.168 | 32.883 | 27.346 | 31.385 | 27.342 | 8.5 | 2.037 | 2.636 | 15.2 | 16.4 | 14.9 | 53.048 | 42.521 | 33.027 | 32.272 | 28.799 | 24.155 | 0 | 0 | 0 | 0 | 0 | 0 | 1.533 | 1.379 |
| Gross Profit
| -28.404 | -29.042 | -22.89 | -24.365 | -24.733 | -26.007 | -6.401 | 0.309 | -1.171 | -12.71 | -12.551 | -10.972 | -38.602 | -28.409 | -21.262 | -18.323 | -0.78 | -18.609 | 2.514 | 2.501 | 2.206 | 1.26 | 4.724 | 4.325 | 10.134 | 5.332 |
| Gross Profit Ratio
| -23.99 | -9.29 | -2.291 | -8.173 | -3.718 | -19.481 | -3.05 | 0.132 | -0.799 | -5.104 | -3.261 | -2.793 | -2.672 | -2.013 | -1.807 | -1.314 | -0.028 | -3.355 | 1 | 1 | 1 | 1 | 1 | 1 | 0.869 | 0.795 |
| Reseach & Development Expenses
| 28.06 | 32.168 | 32.883 | 27.346 | 17.561 | 27.349 | 30.359 | 26.419 | 32.138 | 49.824 | 50.063 | 48.679 | 0 | 0 | 0 | 0 | 0 | 0 | 20.011 | 20.257 | 19.078 | 21.057 | 22.523 | 21.81 | 20.863 | 17.927 |
| General & Administrative Expenses
| 3.818 | 3.221 | 2.594 | 2.315 | 3.434 | 3.5 | 2.4 | 2.2 | 2.7 | 3.6 | 3.2 | 3.6 | 6.226 | 6.296 | 6.147 | 5.256 | 5.747 | 3.928 | 4.173 | 4.274 | 3.553 | 2.926 | 6.888 | 4.309 | 4.684 | 3.402 |
| Selling & Marketing Expenses
| 3.111 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6.929 | 3.221 | 2.594 | 2.315 | 3.434 | 3.5 | 2.4 | 2.2 | 2.7 | 3.6 | 3.2 | 3.6 | 6.226 | 6.296 | 6.147 | 5.256 | 5.747 | 3.928 | 4.173 | 4.274 | 3.553 | 2.926 | 6.888 | 4.309 | 4.684 | 3.402 |
| Other Expenses
| -1.337 | -2.136 | -1.738 | -2.354 | 10.88 | 34.644 | 0.59 | 1.506 | 0.245 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.004 | 0.017 | 0.015 | 0.017 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 34.989 | 33.253 | 33.739 | 27.307 | 31.875 | 28.6 | 30.701 | 26.237 | 29.726 | 44.391 | 45.059 | 46.054 | 6.226 | 6.196 | 6.073 | 3.631 | 6.678 | 3.905 | 24.184 | 24.343 | 22.539 | 23.983 | 29.411 | 26.119 | 27.08 | 22.707 |
| Operating Income
| -35.391 | -29.904 | -23.525 | -23.993 | -25.454 | 7.368 | -28.043 | -22.664 | -35.807 | -46.932 | -41.198 | -42.135 | -44.828 | -34.605 | -27.335 | -21.954 | -7.458 | -22.514 | -21.67 | -21.936 | -20.379 | -24.323 | -24.687 | -21.794 | -13.881 | -14.617 |
| Operating Income Ratio
| -29.891 | -9.566 | -2.354 | -8.049 | -3.827 | 5.519 | -13.36 | -9.661 | -24.442 | -18.848 | -10.704 | -10.727 | -3.103 | -2.452 | -2.323 | -1.574 | -0.266 | -4.06 | -8.62 | -8.771 | -9.238 | -19.304 | -5.226 | -5.039 | -1.19 | -2.178 |
| Total Other Income Expenses Net
| 6.613 | -2.9 | 3.989 | 6.762 | 6.65 | 0.658 | -4.231 | -1.519 | -2.102 | -0.801 | -0.73 | -0.594 | 1.426 | 0.386 | 0 | 3.954 | 1.937 | 0.483 | 0.489 | 1.061 | 2.012 | 2.298 | 1.941 | 2.752 | 1.703 | 0.919 |
| Income Before Tax
| -28.778 | -32.804 | -19.536 | -17.231 | -18.804 | 8.026 | -32.274 | -24.183 | -37.909 | -47.733 | -41.928 | -42.729 | -43.402 | -34.219 | 0 | -18 | -5.521 | -22.031 | -21.181 | -20.875 | -18.367 | -22.025 | -22.746 | -19.042 | -37.043 | -13.698 |
| Income Before Tax Ratio
| -24.306 | -10.494 | -1.955 | -5.78 | -2.827 | 6.012 | -15.376 | -10.308 | -25.876 | -19.17 | -10.893 | -10.878 | -3.004 | -2.425 | 0 | -1.29 | -0.197 | -3.972 | -8.425 | -8.347 | -8.326 | -17.48 | -4.815 | -4.403 | -3.175 | -2.041 |
| Income Tax Expense
| -6.45 | 0.006 | 0.468 | 1.219 | 2.556 | 0.02 | -3.095 | 0.5 | 14.464 | 5.746 | 0.921 | 0.518 | 0.224 | 0 | 0.012 | 0 | 0 | 0 | -0.696 | 0.188 | 0.039 | -0.078 | -0.267 | -0.818 | -2.044 | -1.839 |
| Net Income
| -22.328 | -32.81 | -20.004 | -18.45 | -21.36 | 8.026 | -32.274 | -25.207 | -46.374 | -48.556 | -42.858 | -43.203 | -43.626 | -34.219 | -27.347 | -18 | -5.521 | -22.031 | -20.485 | -20.875 | -18.406 | -21.947 | -22.479 | -18.224 | -35 | -11.859 |
| Net Income Ratio
| -18.858 | -10.496 | -2.002 | -6.189 | -3.211 | 6.012 | -15.376 | -10.745 | -31.655 | -19.5 | -11.135 | -10.999 | -3.02 | -2.425 | -2.324 | -1.29 | -0.197 | -3.972 | -8.148 | -8.347 | -8.344 | -17.418 | -4.758 | -4.214 | -3 | -1.767 |
| EPS
| -0.22 | -0.33 | -0.22 | -0.22 | -0.26 | 0.13 | -0.51 | -0.45 | -1.2 | -1.26 | -1.34 | -1.36 | -1.34 | -1.2 | -1.21 | -0.79 | -0.27 | -1.36 | -1.97 | -2 | -1.77 | -2.52 | -3.76 | -3.1 | -6.61 | -3.38 |
| EPS Diluted
| -0.22 | -0.33 | -0.22 | -0.22 | -0.26 | 0.13 | -0.51 | -0.44 | -1.17 | -1.23 | -1.31 | -1.33 | -1.34 | -1.2 | -1.21 | -0.79 | -0.27 | -1.36 | -1.97 | -2 | -1.77 | -2.52 | -3.76 | -3.1 | -5.96 | -3.38 |
| EBITDA
| -33.805 | -30.308 | -16.547 | -14.226 | -15.478 | 10.81 | -29.447 | -20.921 | -27.172 | -38.97 | -38.296 | -39.328 | -42.088 | -32.192 | -23.575 | -18.291 | -5.148 | -20.923 | -20.247 | -20.295 | -18.855 | -19.674 | -22.881 | -19.885 | -15.413 | -15.996 |
| EBITDA Ratio
| -28.552 | -9.695 | -1.656 | -4.772 | -2.327 | 8.097 | -14.029 | -8.918 | -18.547 | -15.651 | -9.95 | -10.012 | -2.913 | -2.281 | -2.004 | -1.311 | -0.184 | -3.773 | -8.054 | -8.115 | -8.547 | -15.614 | -4.844 | -4.598 | -1.321 | -2.384 |